Nimazone

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C11H9ClN4O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N71M372MP4, chemically known as 1-imidazolidineacetonitrile, 3-(p-chlorophenyl)-4-imino-2-oxo- but generally known as nimazone, which bears US NIH Compound Identifier 28418. European Medicines Agency schedules Nimazone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09293MIG. The term NIMAZONE is an International Non-Proprietary Name. NIMAZONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule nimazone under HS 29332990 and SITC 51573. As of Q4 2014, NIMAZONE remains the US FDA Preferred Term for this commodity. Nimazone bears US NLM identifiers UMLS ID C2347354 and NCI Concept Code C73090. SMILES: C1C(=N)N(C(=O)N1CC#N)C2=CC=C(C=C2)CL.